Cardio Diagnostics Holdings, Inc.
Datakwaliteit: 100%
€ 1,83
▲
€ 0,02
(1,11%)
Marktkapitalisatie: 5,36 M
Prijs
€ 1,81
Marktkapitalisatie
5,36 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—
Quick Summary
Belangrijkste Punten
Negative free cash flow of -5,91 M
Capital intensive — 1263,52% of revenue goes to capex
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)-57,51%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-72,70%
Onder sectorgemiddelde (-53,34%)
ROIC-55,63%
Net Margin-43832,49%
Op. Margin-43737,46%
Veiligheid
Debt / Equity
N/A
Current Ratio17,39
Interest Coverage-438,08
Waardering
PE (TTM)
-0,82
Boven sectorgemiddelde (-1,47)
P/B Ratio0,66
EV/EBITDAN/A
Dividend YieldN/A
Koershistorie
Financiële Trends
Sectorvergelijking
vs Manufacturing sector mediaan (1364 peers)
Sectorvergelijking
vs Manufacturing sector mediaan (1364 peers)| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -0,8 | -1,5 |
| P/B | 0,7 | 1,6 |
| ROE % | -72,7 | -53,3 |
| Net Margin % | -43832,5 | -41,5 |
| Rev Growth 5Y % | — | 1,8 |
| D/E | — | 0,3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -57,51% | Revenue Growth (3Y) | -6,79% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 14.825,0 | Net Income (TTM) | -6,50 M |
| ROE | -72,70% | ROA | -67,74% |
| Gross Margin | N/A | Operating Margin | -43737,46% |
| Net Margin | -43832,49% | Free Cash Flow (TTM) | -5,91 M |
| ROIC | -55,63% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 17,39 |
| Interest Coverage | -438,08 | Asset Turnover | 0,00 |
| Working Capital | 6,53 M | Tangible Book Value | 8,15 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -0,82 | Forward P/E | N/A |
| P/B Ratio | 0,66 | P/S Ratio | 361,32 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -110,41% | ||
| Market Cap | 5,36 M | Enterprise Value | 5,36 M |
| Per Share | |||
| EPS (Diluted TTM) | -3,71 | Revenue / Share | 0,01 |
| FCF / Share | -2,00 | OCF / Share | -1,94 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | 1263,52% | FCF Conversion | 91,01% |
| SBC-Adj. FCF | -6,02 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2021 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 14.825,0 | 34.890,0 | 17.065,0 | — | 950,0 |
| Net Income | -6,50 M | -8,38 M | -8,38 M | -144.837,0 | -4,66 M |
| EPS (Diluted) | -3,71 | -0,31 | -0,66 | — | -1,51 |
| Gross Profit | — | — | — | — | — |
| Operating Income | -6,48 M | -8,37 M | -7,24 M | -145.321,0 | -4,55 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 641.212,0 | 29.125,0 | 145.182,0 | — | 40.448,0 |
| SG&A Expenses | — | — | — | — | — |
| D&A | 65.233,0 | 19.738,0 | 19.182,0 | — | 16.000,0 |
| Interest Expense | 14.801,0 | 18.640,0 | 6,74 M | — | — |
| Income Tax | — | — | — | — | 0,0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2021 | FY2022 |
|---|---|---|---|---|---|
| Total Assets | 7,77 M | 10,62 M | 4,46 M | 65,81 M | 6,25 M |
| Total Liabilities | 793.061,0 | 1,06 M | 1,50 M | 124.434,0 | 1,95 M |
| Shareholders' Equity | 6,97 M | 9,56 M | 2,96 M | 682.732,0 | 4,30 M |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Current Assets | 5,92 M | 8,79 M | 2,77 M | 806.682,0 | 5,89 M |
| Current Liabilities | 604.839,0 | 631.695,0 | 841.142,0 | 124.434,0 | — |
{"event":"ticker_viewed","properties":{"ticker":"CDIO","listing_kind":"stock","pathname":"/stocks/cdio","exchange":"Nasdaq","country":"US"}}